EU-OPENSCREEN welcomes Sweden as a member of their not-for-profit European Research Infrastructure Consortium (ERIC). The integrated CBCS platform at SciLifeLab Karolinska Institutet and Umeå University will lead the Swedish collaboration.
EU-OPENSCREEN ERIC recently announced that two Swedish official partner sites have passed the partner site selection procedure, the Chemical Biology Center at Umeå University (CBCS-UmU), as well as the Department of Medical Biochemistry and Biophysics at the Karolinska Institutet (CBCS-KI) in Stockholm. The Swedish Research Council will be the representing entity.
“We are delighted that Sweden becomes a member of our research infrastructure. Our new partners at Karolinska Institutet and Umeå University have an impressive track record in molecular medicine. We are proud to have them on board to support our growing number of scientific collaborations”, says Wolfgang Fecke, Director of EU-OPENSCREEN in a press release.
The Chemical Biology Consortium Sweden (CBCS) is a national research infrastructure and became a SciLifeLab platform in 2013. The consortium is represented at Sweden’s six largest universities, with different local focus areas. They will offer assay development support, compound screening services, and hit-to-lead guidance in BSL2 and BSL3.
“Sweden has been a partner in EU-OPENSCREEN since the preparatory phase, and the achievements of the CBCS over the last decade are impressive. We are glad to see that the EU-OPENSCREEN community is growing with two new member countries and new partner sites, which joined this year” says Bahne Stechmann, Head of Operations and Scientific Strategy.
“The collaboration with EU-OPENSCREEN is a decisive step in the right direction for the Swedish Chemical Biology Consortium and opens up new opportunities for us to contribute our expertise in new projects and to advance research in Europe”, says SciLifeLab researcher and CBCS Director Anna-Lena Gustavsson (KI).
CBCS is also part of the Chemical Biology and Genome Engineering (CBGE) platform at SciLifeLab, including the CRISP Functional Genomics and Chemical Proteomics units, that will now complement the expertise of EU-OPENSCREEN.
Read more about the CBCS-UmU and CBCS-KI capabilities in the EU-OPENSCREEN press release.